BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 12123788)

  • 1. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals.
    Seimbille Y; Rousseau J; Bénard F; Morin C; Ali H; Avvakumov G; Hammond GL; van Lier JE
    Steroids; 2002 Aug; 67(9):765-75. PubMed ID: 12123788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
    VanBrocklin HF; Carlson KE; Katzenellenbogen JA; Welch MJ
    J Med Chem; 1993 May; 36(11):1619-29. PubMed ID: 7684451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780).
    Seimbille Y; Bénard F; Rousseau J; Pepin E; Aliaga A; Tessier G; van Lier JE
    Nucl Med Biol; 2004 Aug; 31(6):691-8. PubMed ID: 15246359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative breast tumor imaging and comparative in vitro metabolism of 16alpha-[18F]fluoroestradiol-17beta and 16beta-[18F]fluoromoxestrol in isolated hepatocytes.
    Jonson SD; Bonasera TA; Dehdashti F; Cristel ME; Katzenellenbogen JA; Welch MJ
    Nucl Med Biol; 1999 Jan; 26(1):123-30. PubMed ID: 10096512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis of 7 alpha-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents.
    VanBrocklin HF; Liu A; Welch MJ; O'Neil JP; Katzenellenbogen JA
    Steroids; 1994 Jan; 59(1):34-45. PubMed ID: 8140600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated synthesis of 11beta-methoxy-4,16alpha-[16alpha-(18)F]difluoroestradiol (4F-M[(18)F]FES) for estrogen receptor imaging by positron emission tomography.
    Ahmed N; Langlois R; Rodrigue S; Bénard F; van Lier JE
    Nucl Med Biol; 2007 May; 34(4):459-64. PubMed ID: 17499736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of 16alpha-[18F]-fluoroestradiol (FES) with sex steroid binding protein (SBP).
    Tewson TJ; Mankoff DA; Peterson LM; Woo I; Petra P
    Nucl Med Biol; 1999 Nov; 26(8):905-13. PubMed ID: 10708304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol.
    Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J
    Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of 17-ethynyl-substituted 16 alpha-[18F]fluoroestradiols: selective receptor-based PET imaging agents.
    VanBrocklin HF; Pomper MG; Carlson KE; Welch MJ; Katzenellenbogen JA
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):363-74. PubMed ID: 1629026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
    Yoo J; Dence CS; Sharp TL; Katzenellenbogen JA; Welch MJ
    J Med Chem; 2005 Oct; 48(20):6366-78. PubMed ID: 16190762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity.
    Pomper MG; VanBrocklin H; Thieme AM; Thomas RD; Kiesewetter DO; Carlson KE; Mathias CJ; Welch MJ; Katzenellenbogen JA
    J Med Chem; 1990 Dec; 33(12):3143-55. PubMed ID: 1701833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.
    Bénard F; Ahmed N; Beauregard JM; Rousseau J; Aliaga A; Dubuc C; Croteau E; van Lier JE
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1473-9. PubMed ID: 18360749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of the alkyl side chain length of fluorine-18-labeled 7α-alkyl-fluoroestradiol.
    Okamoto M; Shibayama H; Naka K; Kitagawa Y; Ishiwata K; Shimizu I; Toyohara J
    Nucl Med Biol; 2016 Aug; 43(8):512-9. PubMed ID: 27289329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
    Jonson SD; Welch MJ
    Q J Nucl Med; 1998 Mar; 42(1):8-17. PubMed ID: 9646640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using
    Jager A; de Vries EGE; der Houven van Oordt CWM; Neven P; Venema CM; Glaudemans AWJM; Wang Y; Bagley RG; Conlan MG; Aftimos P
    Breast Cancer Res; 2020 Sep; 22(1):97. PubMed ID: 32912274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and breast tumor uptake of 16alpha-[18F]-fluoro-17beta-estradiol in rat.
    Sasaki M; Fukumura T; Kuwabara Y; Yoshida T; Nakagawa M; Ichiya Y; Masuda K
    Ann Nucl Med; 2000 Apr; 14(2):127-30. PubMed ID: 10830531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of A-ring fluorinated derivatives of (17 alpha,20E/Z)-[125I]iodovinylestradiols: effect on receptor binding and receptor-mediated target tissue uptake.
    Ali H; Rousseau J; van Lier JE
    J Med Chem; 1993 Oct; 36(21):3061-72. PubMed ID: 8230092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
    Paquette M; Ouellet R; Archambault M; Croteau É; Lecomte R; Bénard F
    Nucl Med Biol; 2012 Jan; 39(1):57-64. PubMed ID: 22079037
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
    Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.